Other
Pre-tax stock-based compensation cost
Medtronic Pre-tax stock-based compensation cost decreased by 47.8% to $95.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from $98.00M to $95.00M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID:
other_allocated_share_based_compensation_expenseHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.00M | $140.00M | $78.00M | $62.00M | $137.00M | $81.00M | $73.00M | $146.00M | $85.00M | $83.00M | $159.00M | $98.00M | $86.00M | $182.00M | $95.00M |
| QoQ Change | — | +102.9% | -44.3% | -20.5% | +121.0% | -40.9% | -9.9% | +100.0% | -41.8% | -2.4% | +91.6% | -38.4% | -12.2% | +111.6% | -47.8% |
| YoY Change | — | — | — | -10.1% | -2.1% | +3.8% | +17.7% | +6.6% | +4.9% | +13.7% | +8.9% | +15.3% | +3.6% | +14.5% | -3.1% |
Range$62.00M – $182.00M
CAGR+9.6%
Avg YoY Growth+6.1%
Median YoY Growth+5.8%
Pre-tax stock-based compensation cost at Other Companies
Frequently Asked Questions
- What is Medtronic's pre-tax stock-based compensation cost?
- Medtronic (MDT) reported pre-tax stock-based compensation cost of $95.00M in Q4 2025.
- How has Medtronic's pre-tax stock-based compensation cost changed year-over-year?
- Medtronic's pre-tax stock-based compensation cost decreased by 3.1% year-over-year, from $98.00M to $95.00M.